Biomarkers that predict improved outcomes after perioperative immune-based therapy for lung cancer

September 2, 2026 · 12:00 am 1 sources

Image: Nature

Coverage

Wires & papers of record

• Biomarkers that predict improved outcomes after perioperative immune-based therapy for lung cancer
  Nature · September 2, 2026 00:00
  Nature, Published online: 02 September 2026; doi:10.1038/d41586-026-02486-5 Comprehensive exploratory analyses of biomarkers were done in the phase III CheckMate 77T study of pre- and post-surgical treatment with the immunotherapy nivolumab in individuals with surgically resectable non-small-cell…